Delivery Order SPE2DR25D2212-SPE2DR26FB9HE
- Not listed
- The Defense Logistics Agency awarded a $1,809.50 delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector supplies, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract utilizing AmerisourceBergen's existing indefinite delivery vehicle with DLA. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Xyosted 100 mg/0.5 mL auto-injector units valued at $1,713.40. This firm fixed price delivery order, awarded on November 13, 2025, represents a non-set-aside competitive award with an ultimate completion date of November 14, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,230.21 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector units on August 6, 2025, with completion targeted for August 7, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded procurement from AmerisourceBergen's existing pharmaceutical supply contract with DLA. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $1,257.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector supplies on December 3, 2025, with completion targeted for December 4, 2025. This non-set-aside award represents a small-value transaction under AmerisourceBergen's broader relationship with DLA for pharmaceutical and medical supply distribution. The delivery location is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,146.22 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector supplies. This is a firm fixed price delivery order with no set-aside designation, issued on September 19, 2025, with a completion date of September 22, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,429.20 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 11, 2025, issued on September 10, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,866.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xyosted 50 mg/0.5 mL auto-injector units, with a completion date of November 19, 2025. This non-set-aside competitive award represents a single delivery order for pharmaceutical products under AmerisourceBergen's larger contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a $1,711.16 delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector units on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price contract represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,085.32 firm fixed price delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector supplies, with performance completion targeted for November 3, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order valued at $2,021.45 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 ml auto-injector supplies. This competitive award, issued on December 1, 2025, represents a firm fixed price delivery order with an ultimate completion date of December 2, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a...
- SPE2DR25D2212Indefinite Delivery Contract
- SPE2DR25D2212-SPE2DR26FB9HEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,813.47 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector supplies on November 24, 2025, with completion targeted for November 25, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction for pharmaceutical supplies to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a primary distribution center for its federal healthcare operations. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs, the Defense Health Agency, and other federal healthcare systems. AmerisourceBergen's established position as a major pharmaceutical distributor, combined with its substantial prime IDC with DLA, demonstrates the company's capability to meet federal medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/23/25 |